Bulk Manufacturer of Controlled Substances Application: S&B Pharma Inc., 8116 [2019-04030]
Download as PDF
<![CDATA[
8116
Federal Register / Vol. 84, No. 44 / Wednesday, March 6, 2019 / Notices
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
Dated: February 18, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–04031 Filed 3–5–19; 8:45 am]
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 6, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: S&B Pharma
Inc.
ACTION:
Notice of application.
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
February 28, 2017, S&B Pharma Inc.,
405 South Motor Avenue, Azusa,
California 91702–3232 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Controlled substance
Drug code
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Amphetamine ..........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ...................................................................................................................................................
Methylphenidate ......................................................................................................................................................
Pentobarbital ...........................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .............................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to manufacture
the listed controlled substances in bulk
for use in product development and for
commercial sales to its customers. In
reference to drug codes 7360
(marihuana) and 7370 (THC), the
company plans to bulk manufacture
both as synthetic substances. No other
activity for these drug codes is
authorized for this registration.
Dated: February 18, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–04030 Filed 3–5–19; 8:45 am]
BILLING CODE 4410–09–P
The
company listed below applied to be
registered as a bulk manufacturer of
various basic classes of controlled
substances. Information on a previously
published notice is listed below. No
comments or objections were submitted
for the notice.
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
Notice of registration.
The registrant listed below
has applied for and been granted a
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule I and II controlled substances.
SUMMARY:
Company
FR Docket
Eli-Elsohly Laboratories ........................................................
83 FR 64159 ........................................................................
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
VerDate Sep<11>2014
18:35 Mar 05, 2019
Jkt 247001
I
I
II
II
II
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
ACTION:
7360
7370
1100
1105
1205
1724
2270
8333
9780
9801
Schedule
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Published
December 13, 2018.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
E:\FR\FM\06MRN1.SGM
06MRN1
]]>Agencies
[Federal Register Volume 84, Number 44 (Wednesday, March 6, 2019)]
[Notices]
[Page 8116]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04030]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: S&B
Pharma Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before May 6, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
February 28, 2017, S&B Pharma Inc., 405 South Motor Avenue, Azusa,
California 91702-3232 applied to be registered as a bulk manufacturer
of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana....................... 7360 I
Tetrahydrocannabinols........... 7370 I
Amphetamine..................... 1100 II
Methamphetamine................. 1105 II
Lisdexamfetamine................ 1205 II
Methylphenidate................. 1724 II
Pentobarbital................... 2270 II
4-Anilino-N-phenethyl-4- 8333 II
piperidine (ANPP).
Tapentadol...................... 9780 II
Fentanyl........................ 9801 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for use in product development and for commercial sales to its
customers. In reference to drug codes 7360 (marihuana) and 7370 (THC),
the company plans to bulk manufacture both as synthetic substances. No
other activity for these drug codes is authorized for this
registration.
Dated: February 18, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-04030 Filed 3-5-19; 8:45 am]
BILLING CODE 4410-09-P
